HUB Organoids https://validator.w3.org/feed/docs/rss2.html About HUB Metastatic Colorectal Cancer Drug Screening with Patient-Derived Organoids Patient-Derived Organoid Services | Drug Screening & Assay Development PDO Screen | Patient-derived organoid screen | Accelerate Oncology Research Patient-Derived Organoids Predict Treatment Response in Metastatic Colorectal Cancer How we modelled human fibroblast-epithelial interactions with organoids to identify IBD targets How organoid data guided our client in selecting a human-relevant animal model for preclinical toxicology studies How we helped our client anticipate on- and off-target toxicity using patient-derived organoids Apply for a license LP Podcast Episode 3: Organoid Platforms for Drug Discovery and Safety Organoids Podcasts Accelerating personalized medicine: miniaturized patient-derived organoid drug screening for predicting cancer treatment responses and beyond How we supported our client in advancing biomarker discovery and translational ADC development Patient-Derived Organoids: A New Frontier in ADC Development Podcast Episode 2: Modelling colorectal cancer progression in a dish How we supported our client translate animal toxicity data to human-relevant insights and identify a therapeutic window Organoid Toxicology case study: How we helped our client anticipate on- and off-target toxicity using patient-derived organoids License HUB Organoid Technology Meet Us Podcast Episode 1: Discovery of adult-stem cell derived organoids HUB Drug Screening Services | Patient-Derived Organoid Solutions Immuno-Oncology HUB Organoid Technology | Patient-Derived Organoids for Drug Discovery Patient-derived Organoids: Transforming Infectious Disease Research and Drug Development From Patient to Platform Challenges in Drug Development: Fail Fast, Capital Efficiency Strategy & Portfolio Optimization with HUB Organoids Patient-derived organoids of Inflammatory diseases | IBD | organoid co-culture Regulators Embrace Organoids: Inside the FDA’s Shift Away from Animal Model Advancing immunotherapy for solid tumors with patient-derived organoids How we enabled our client to bring an oncology clinical candidate to patients within five years How we enabled our client to assess efficacy and selectivity of a bispecific antibody using organoid-based co-cultures How we modelled human fibroblast-epithelial interactions with organoids to identify IBD targets Organoid Toxicology case study: How organoid data guided our client in selecting a human-relevant animal model for preclinical toxicology studies How we enabled our client to assess efficacy and selectivity of a bispecific antibody using organoid-based co-cultures Organoid Toxicology Case Study : How we supported our client translate animal toxicity data to human-relevant insights and identify a therapeutic window Careers Patient-derived organoids as translational avatars for KRAS research Model Dev DD Patient-derived organoids of Infectious Diseases | Organoids CRO Case Study: Preclinical Drug Development How we supported our client in advancing biomarker discovery and translational ADC development Organoid-based Solutions for KRAS Inhibitor Testing Organoids in Oncology Drug Development | Services Antibody-Drug-Conjugate Solutions | ADC | Organoid Technology Ask the Expert: Inside the inFOCUS Assay for IBD Drug Discovery Minimizing Oncology Drug Failure Rates Using Organoid Modeling and Multi-omic Data PDO Monolayer | Physiologically-relevant solutions for Inflammatory bowel disease | Intestinal organoid Oncology <span>HUB</span> News Patient-derived organoids CRO | Drug discovery | Organoid development services